Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1